St Joseph's Healthcare Hamilton, 100 West 5th St, Hamilton, ON, L8N 3K7, Canada
J Clin Psychiatry. 2014;75 Suppl 2:20-4. doi: 10.4088/JCP.13065su1.05.
Despite many advances in the treatment of schizophrenia over the past 50 years, the outcomes for many patients with schizophrenia remain poor. While the majority of patients with a first episode of schizophrenia may be able to achieve and maintain a remission of symptoms, only 1 in 7 patients are likely to meet criteria for recovery. These findings could be easily reconciled if schizophrenia could be established to be a progressive brain disease. Results from longitudinal studies of brain structure, cognitive functioning, and clinical outcomes, however, do not support this view. The poor outcomes so commonly observed are likely best explained by poor access to treatment, poor engagement in ongoing care, poor treatment response, and poor adherence together with the cumulative negative impact of substance abuse, comorbid psychiatric disorders, cognitive deficits, and multiple social determinants of health.
尽管在过去的 50 年中,精神分裂症的治疗取得了许多进展,但许多精神分裂症患者的治疗效果仍然不佳。虽然大多数首次发作的精神分裂症患者可能能够实现并维持症状缓解,但只有 1/7 的患者可能符合康复标准。如果精神分裂症能够被确定为一种进行性的脑部疾病,这些发现就很容易得到解释。然而,对大脑结构、认知功能和临床结果的纵向研究结果并不支持这种观点。如此常见的不良预后,很可能是由于治疗机会有限、持续治疗参与度低、治疗反应不佳以及药物滥用、共病精神障碍、认知缺陷和多种健康的社会决定因素的累积负面影响所致。